Dr. Richard Nevin Selby M.D.

Recommended Articles

• Dementia and Related Psychosis: Should Antipsychotic Drugs Really Be Used?

  Alzheimer’s is one of the primary causes of age-related dementia, and it's typically characterized by the progressive loss of connectivity between brain cells and their death, leading not only to the loss of memory and cognition, but also difficulties in social interaction.As the disease...

• How Some Muscular Dystrophy Patients Live Life to the Fullest

  Muscular Dystrophy (MD) is a group of genetic disorders that cause the muscles of the body to weaken and fail over time. There are different types of MD that are all characterized by gene mutations, and each type affects patients differently and in different areas of the body, as well as at...

• Sarepta Sheds Light on Next Generation Drug for Muscular Dystrophy Patients

  Each company has faced its own set of issues, with Sarepta being one of many that are trying to make amends for some issues that have happened in the past. Although there happened to be some issues with the data that was coming from Sarepta, their approval of the drug that can assist with muscular...

• What Are the Signs and Symptoms of Stroke?

  Stroke can occur at any time of your life. However, those who have attained 65+ years are more prone to getting a stroke. It is also important to note that other factors such as family history, alcohol, smoking, medical history, and your ethnicity can trigger the occurrence of stroke. If you think...

• Opening Up About A Parkinson’s Diagnosis

  Being diagnosed with Parkinson’s can be a huge life-changer for anyone. Unfortunately, it is a progressive disease, so even with the help of surgery and medication, some parts of it will remain as part of your life. It can be possible, especially during the early stages of the disease, to live...

• Subtle Changes in Speech Can Signify Early Dementia, Study Says

  Filler words, rambling, repetition, and vague word choices could signal a future diagnosis of Alzheimer’s, according to new research presented at the Alzheimer’s Association in July 2017.During the London conference, Professor Kimberly Mueller from University of Wisconsin-Madison outlined these...